about
Should parasitic disease be investigated in immigrant children with relative eosinophilia from tropical and sub-tropical regions?Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones.Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry.Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Rapid method for direct identification of bacteria in urine and blood culture samples by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: intact cell vs. extraction method.Identification of Brucella by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures[Proteomic applications in the Clinical Microbiology laboratory].[Reliability of MALDI-TOF mass spectrometry in the identification of anaerobic bacteria].Identification of fungal clinical isolates by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.Pretreatment of urine samples with SDS improves direct identification of urinary tract pathogens with matrix-assisted laser desorption ionization-time of flight mass spectrometryIn vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activityIn vitro activities of irloxacin and E-3846, two new quinolonesIn vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.[MALDI-TOF mass spectrometry in clinical microbiology. Current situation and future perspectives].[Historical perspective of mass spectrometry in microbiology].Relevance of eosinophilia and hyper-IgE in immigrant children.Fast methods of fungal and bacterial identification. MALDI-TOF mass spectrometry, chromogenic media.In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.[Prevalence of anti-Chlamydophila pneumoniae antibodies in patients with intrinsic asthma.]Screening for parasite infections in immigrant children from low-income countries.Imported transmissible diseases in minors coming to Spain from low-income areas.Emergence of quinolone-resistant, topoisomerase-mutant Brucella after treatment with fluoroquinolones in a macrophage experimental infection model.Unusual clinical presentations of Actinotignum (Actinobaculum) schaalii infection.[Serratia marcescens outbreak due to contaminated 2% aqueous chlorhexidine].Genitourinary tuberculosis in Spain: review of 81 cases.Full coding hepatitis E virus genotype 3 genome amplification method.Cfr-mediated linezolid resistance in methicillin-resistant Staphylococcus aureus and Staphylococcus haemolyticus associated with clinical infections in humans: two case reports.[Fusidic Acid]In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.Efficacy of topical ciprofloxacin in the treatment of ear infections in adults.[Antimicrobial drug resistance in non-typhi Salmonellae in Castilla y Leon][Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?].Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.[Atypical serologic patterns in hepatitis B virus infection][Wide-spectrum beta-lactamases: are they a serious problem today in Spain?][Do ketolides have real advantages over macrolides?]The role of fluoroquinolones in respiratory tract infections: community acquired pneumonia.[Activity of new quinolones against clinical isolates of Corynebacterium species]
P50
Q28271913-9085E2E4-2FB3-4056-9B69-7E44ED4DD9F9Q31830909-8781284B-3E37-42A7-9EC9-931C68C0CB17Q33555783-537E229C-B736-4EAD-AC02-9B6D4006CB1BQ33574046-052C572D-3193-41CB-9476-5D4BF5A04C23Q33662470-0385B713-DA6E-4907-B264-272713C59A47Q33769422-102BED6E-0D41-465C-8443-1136A1CB78D6Q34143789-30914C8A-7F7B-4E6F-A04B-634A14FE5AE2Q34240945-FF1DE6B0-9859-41DD-8E26-130D59CA9D4AQ35002787-C08BAAC9-4C72-4B2B-A587-42AFBD8E32DAQ35042162-8C375D9F-EDD6-4355-A608-CB730F71F216Q35139268-E9EFE022-FBE1-4E0E-9C56-B9C92843448CQ35263647-4E4F32AC-6750-4474-9848-2F07D1C51908Q35352378-35523386-5D88-435D-B14A-D6D9ED30FBF8Q35626118-FCC658D2-F370-4130-AA2E-25EC028A7CC2Q36070465-FA9E969A-C318-464D-BC2F-B19C0413C1BAQ36150805-C3D7D746-E245-4F7D-8B70-A9A88EB8189FQ36256112-17B68EAE-E440-40F0-B45E-47FB7AE23635Q36756119-B1D05C17-DDFB-4D77-A456-DB159377C729Q37864077-76485B52-690D-41FA-9499-F30FA836DC82Q38900863-510F5406-499C-495C-A2B6-BB0FB49F1157Q38900867-CD05859A-B718-4C08-BC92-BA2670402389Q38986315-D89D1B5C-CF06-4CA5-8835-C27CC797233DQ40465262-8D883016-16A1-4D11-BBAE-ACB33C1F613BQ40586787-94632F12-5BED-4F80-9BD0-8373FF5AA0EEQ40675877-F732C07E-22B2-4686-A905-600417887425Q40827067-A1764A86-16CF-47C8-8C0A-B605CDEA7C9DQ43656554-6C73AAD8-8F53-4A7D-8554-0A4D2EC00A7FQ44584469-2F448A24-019F-4699-A566-489601F196D9Q44645268-951244C6-7AD8-4C62-A814-CDCB296FA780Q44729042-E1F97476-089D-4071-8843-C59F28162A89Q44940191-8C3E048C-BCC4-4317-A984-5E7926FDD880Q45016857-39FC9401-477C-4513-92CD-9CE7914D59FBQ46079431-1EEB183A-E276-45CC-8C45-9872B7DF16B0Q46108870-8576CB8F-21D6-4AEA-B967-D0544F91BC31Q50067926-18B988DE-54DC-4190-8BE7-071899760123Q53772851-7B1B295E-8838-45F0-9607-FA739C24B6F8Q53871777-4550CB12-E92F-45D5-B0FB-3C9197EA69D2Q53907051-20F7E8EF-B462-478F-BA8D-9EA3B339D90FQ54028903-F11BF6B8-E0E7-4D04-8EA1-EE2BA0C6A35CQ54029267-7AFB00B9-7078-4E92-9D59-440E2CE6F709
P50
description
researcher ORCID ID = 0000-0002-5981-8785
@en
wetenschapper
@nl
name
Juan Luis Muñoz Bellido
@ast
Juan Luis Muñoz Bellido
@en
Juan Luis Muñoz Bellido
@nl
type
label
Juan Luis Muñoz Bellido
@ast
Juan Luis Muñoz Bellido
@en
Juan Luis Muñoz Bellido
@nl
prefLabel
Juan Luis Muñoz Bellido
@ast
Juan Luis Muñoz Bellido
@en
Juan Luis Muñoz Bellido
@nl
P106
P21
P31
P496
0000-0002-5981-8785